Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT01050504
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study collects and studies tissue and blood samples from patients with prostate or bladder/urothelial cancer that has recurred (come back) at or near the same place as the original (primary) tumor or has spread to other parts of the body. Studying samples of blood and tissue samples from patients with prostate or bladder/urothelial cancer in the laboratory may help doctors learn more about new biomarkers, potential drug targets, and resistance developing in response to treatment. It may also help doctors find better ways to treat the cancer.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Localized Renal Pelvis and Ureter Urothelial Carcinoma
- Malignant Solid Neoplasm
- Metastatic Malignant Neoplasm in the Bone
- Metastatic Malignant Neoplasm in the Soft Tissues
- Metastatic Renal Pelvis and Ureter Urothelial Carcinoma
- Recurrent Bladder Carcinoma
- Recurrent Prostate Carcinoma
- Recurrent Renal Pelvis and Ureter Urothelial Carcinoma
- Stage IV Bladder Cancer AJCC v7
- Stage IV Bladder Urothelial Carcinoma AJCC v7
- Stage IV Prostate Cancer AJCC v7
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- Male
- Healthy volunteers
- Accepted
- Sponsor
- University of Washington
- Last updated on ClinicalTrials.gov
- August 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Washington · 1
- Fred Hutch/University of Washington Cancer Consortium · Seattle, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.